Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Axovant Sciences Ltd (AXON)

1.07 -0.01 (-0.93%)

04-25 16:00

Open:

1.09

Pre. Close:

1.08

High:

1.1168

Low:

1.03

Volume:

219,511

Market Cap:

115M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.123 - 1.129

1.129 - 1.134

Low:

1.012 - 1.02

1.02 - 1.027

Close:

1.057 - 1.07

1.07 - 1.08

Technical analysis  (as of: 2018-04-25 4:24:58 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 1.56     One year: 1.79

Support:

Support1: 1.02    Support2: 0.85

Resistance:

Resistance1: 1.34    Resistance2: 1.53

Pivot:

1.15

Moving Averages:

MA(5): 1.08     MA(20): 1.18

MA(100): 2.54     MA(250): 11.39

MACD:

MACD(12,26): -0.11     Signal(12,26,9): -0.12

%K %D:

%K(14,3): 15.05     %D(3): 11.25

RSI:

RSI(14): 30.95

52-Week:

High: 27.976  Low: 1.02  Change(%): -95.6

Average Vol(K):

3-Month: 85223  10-Days 42417

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AXON has closed above bottom band by 16.9%. Bollinger Bands are 78% narrower than normal. The narrow width of the bands suggests low volatility as compared to AXON's normal range. The bands have been in this narrow range for 61 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-16T16:02:15-04:00
vTv Therapeutics Fails Late-Stage Alzheimer's Study; Is There A Chance For A Comeback?

2018-04-11T12:50:23-04:00
Midday Gainers / Losers (04/11/2018)

2018-04-11T08:00:00-04:00
Your Daily Pharma Scoop: vTv Therapeutics Plunges, Spectrum Provides Updated Data, Selecta Sees Pullback On Data

2018-04-04T11:14:00-04:00
Oryzon Genomics on go with mid-stage study of Alzheimer's candidate ORY-2001

2018-03-05T12:23:33-05:00
Celgene Vs. Biogen: Both Are A Steal, But Which One Is Better?

2018-02-25T20:26:29-05:00
Axovant Sciences: 5 Trials, 4 Failures - Expect A Fifth

2018-02-22T11:53:40-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update

2018-02-15T13:01:49-05:00
Your Daily Pharma Scoop: Shire Looks Attractive, Omeros Data, Axovant Restructuring

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

107.79

Shares Float (M)

107.04

% Held by Insiders

0.70

% Held by Institutions

Shares Short (K)

2430

Shares Short Prior Month (K)

4550

Stock Financials

EPS

-2.090

EPS Est. Current Year

-2.020

EPS Est. Next Year

-2.070

EPS Est. Next Quarter

-0.490

Forward EPS

-1.500

Book Value (p.s.)

1.130

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-123.8

Return on Equity (ttm)

-182.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.739

Qtrly Earnings Growth

Operating Cash Flow (M)

-197.51

Levered Free Cash Flow (M)

-105.46

atoplab.com

Valuation

P/E

-0.51

P/E Growth Ratio

-0.01

P/BV

0.95

P/S

P/CF

-0.58

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.